Advanced

CHEMOTHERAPY Current drugs still have potential in advanced ovarian cancer

Högberg, Thomas LU (2010) In Nature Reviews Clinical Oncology 7(4). p.191-193
Abstract
Dose-dense administration of paclitaxel as well as intraperitoneal administration of platinum and paclitaxel as first-line treatments provide similar advantages compared with standard treatment in advanced ovarian cancer. Both approaches, however, need to be confirmed by additional studies. a low dose of pegylated liposomal doxorubicin combined with carboplatin is superior to standard paclitaxel and carboplatin in relapsed platinum-sensitive ovarian cancer.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Nature Reviews Clinical Oncology
volume
7
issue
4
pages
191 - 193
publisher
Nature Publishing Group
external identifiers
  • wos:000276152300009
  • pmid:20354543
  • scopus:77950497098
ISSN
1759-4782
DOI
10.1038/nrclinonc.2010.37
language
English
LU publication?
yes
id
796086d9-1ee8-4c5c-9fcc-2df37c248905 (old id 1586955)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/20354543?dopt=Abstract
date added to LUP
2010-04-28 07:25:30
date last changed
2018-06-24 03:28:25
@misc{796086d9-1ee8-4c5c-9fcc-2df37c248905,
  abstract     = {Dose-dense administration of paclitaxel as well as intraperitoneal administration of platinum and paclitaxel as first-line treatments provide similar advantages compared with standard treatment in advanced ovarian cancer. Both approaches, however, need to be confirmed by additional studies. a low dose of pegylated liposomal doxorubicin combined with carboplatin is superior to standard paclitaxel and carboplatin in relapsed platinum-sensitive ovarian cancer.},
  author       = {Högberg, Thomas},
  issn         = {1759-4782},
  language     = {eng},
  number       = {4},
  pages        = {191--193},
  publisher    = {Nature Publishing Group},
  series       = {Nature Reviews Clinical Oncology},
  title        = {CHEMOTHERAPY Current drugs still have potential in advanced ovarian cancer},
  url          = {http://dx.doi.org/10.1038/nrclinonc.2010.37},
  volume       = {7},
  year         = {2010},
}